logo
Surf Air Mobility Introduces Flagship SurfOS ™ AI-Enabled Product Suite for Air Mobility Industry

Surf Air Mobility Introduces Flagship SurfOS ™ AI-Enabled Product Suite for Air Mobility Industry

Business Wire10-06-2025
LOS ANGELES--(BUSINESS WIRE)--Surf Air Mobility Inc. (NYSE: SRFM) ('the Company', 'Surf Air Mobility'), a leading regional air mobility platform, today unveiled the three flagship software products of the Company's SurfOS AI-enabled operating system scheduled for broad commercial release in 2026. BrokerOS, OperatorOS, and OwnerOS are purpose-built to address the needs of charter brokers, aircraft operators, and aircraft owners, respectively.
SurfOS will integrate industry data into a single, federated platform, creating an operating system for the Regional Air Mobility industry powered by Palantir Technologies (NASDAQ: PLTR).
Deanna White, CEO and COO of Surf Air Mobility, said: 'From crew scheduling to flight planning to sourcing on-demand charter aircraft, SurfOS is helping our teams work smarter every day. As we roll out more SurfOS tools internally, we will continue to automate manual tasks and improve reliability to ensure our aircraft and crews are operating as efficiently as possible.'
Sudhin Shahani, Co-founder of Surf Air Mobility, said: 'We're creating an operating system that unifies industry data to improve efficiency and increase profitability. Our software will not only serve today's regional and private aviation stakeholders, but is also being built in anticipation of the rapidly approaching era of electrified aircraft. These new electrified aircraft operators will need modern software to manage flight operations and consumer distribution.'
SurfOS flagship products:
BrokerOS consists of software tools specifically tailored for charter brokers. BrokerOS software tools streamline sourcing, quoting, booking, and payments for charter brokers. These tools will reduce manual workflows and will give both new and experienced brokers instant access to available inventory, live pricing, and end-to-end trip management capabilities.
BrokerOS is currently being used to manage the Company's Surf On Demand charter service and, once commercially available, will target the hundreds of Part 295 private charter broker companies and thousands of travel agents worldwide.
OperatorOS consists of software tools specifically tailored for aircraft operators. OperatorOS software tools are designed to optimize aircraft and crew scheduling for both Part 135 charter operators and scheduled commuter airlines. Leveraging these tools, operators can reduce turn times and improve aircraft and pilot utilization by tapping into operational data and automated crew planning. OperatorOS also includes a companion mobile Crew App, currently used by the Company today, that enables flight crews to check in for duty and receive flight schedules and operational updates to streamline day-of-flight coordination.
Once commercially available, OperatorOS will target the 1,800+ Part 135 operators, of which the Company's commuter airline, Southern Airways, is one of the largest in the U.S. by scheduled departures.
OwnerOS consists of software tools specifically tailored for aircraft owners. OwnerOS software tools are designed to deliver transparency and optimization capabilities to private aircraft owners. Through a native integration with OperatorOS, private aircraft owners will gain insight and better visibility into how their assets are being used as well as an interface to support decisions that optimize aircraft utilization to generate better returns on assets.
Once commercially available, OwnerOS will target the owners of the 11.7K+ Part 135 aircraft in use today.
SurfOS currently has beta agreements with eight users that are helping shape the development of key BrokerOS and OperatorOS features.
While SurfOS is positioned to serve the Regional Air Mobility industry, which is projected to be $75–$115 billion globally by 2035, the first commercial software products will have a more immediate impact on today's private aviation landscape. BrokerOS and OperatorOS are designed to address the global private jet charter services market, an estimated $41 billion opportunity by 2029, while OwnerOS is designed to address the estimated $40 billion global private aircraft sales market.
About Surf Air Mobility
Surf Air Mobility is a Los Angeles-based regional air mobility platform and one of the largest commuter airlines in the U.S. by scheduled departures. It is also the largest U.S. passenger operator of Cessna Caravans. In addition to its airline operations and On Demand charter services, Surf Air Mobility is developing an AI-powered software platform for the Regional Air Mobility industry. The company is also working to commercialize electrified aircraft and develop proprietary powertrain technology for the Cessna Caravan. Surf Air Mobility plans to offer its software and electrification solutions to the Regional Air Mobility industry to improve safety, efficiency, and profitability.
Forward-Looking Statements
This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the functionality and timing of the commercial release of SurfOS, the total addressable market for SurfOS, Surf Air's profitability and future financial results and its ability to achieve its business objectives. Readers of this release should be aware of the speculative nature of forward-looking statements. These statements are based on the beliefs of the Company's management as well as assumptions made by and information currently available to the Company and reflect the Company's current views concerning future events. As such, they are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, among many others: Surf Air's ability to anticipate the future needs of the air mobility market; Surf Air's future ability to pay contractual obligations and liquidity will depend on operating performance, cash flow and ability to secure adequate financing; the dependence on third-party partners and suppliers for the components and collaboration in Surf Air's development of its advanced air mobility software platform, and any interruptions, disagreements or delays with those partners and suppliers; the inability to execute business objectives and growth strategies successfully or sustain Surf Air's growth; the inability of Surf Air's customers to pay for Surf Air's services; the inability of Surf Air to obtain additional financing or access the capital markets to fund its ongoing operations on acceptable terms and conditions; the outcome of any legal proceedings that might be instituted against Surf Air, the risks associated with Surf Air's obligations to comply with applicable laws, government regulations and rules and standards of the New York Stock Exchange; and general economic conditions. These and other risks are discussed in detail in the periodic reports that the Company files with the SEC, and investors are urged to review those periodic reports and the Company's other filings with the SEC, which are accessible on the SEC's website at www.sec.gov, before making an investment decision. The Company assumes no obligation to update its forward-looking statements except as required by law.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)
RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)

Yahoo

time13 minutes ago

  • Yahoo

RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)

Abbott Laboratories (NYSE:ABT) ranks among the . RBC Capital maintained its Outperform rating on Abbott Laboratories (NYSE:ABT) on July 15 and raised its price target from $145 to $147. The firm pointed to Abbott's strong single-digit revenue and double-digit EPS growth potential as examples of its ability to provide top-tier financial growth in the medical technology industry. According to RBC Capital's intra-quarter checks, Abbott Laboratories (NYSE:ABT) maintains positive healthcare utilization in Q2. Moreover, Abbott's diabetes brand, which has been attracting a lot of investor interest, was one of the several growth catalysts mentioned in the firm's report. The less elective nature of Abbott's medical device portfolio was also mentioned by RBC as a benefit. RBC Capital's sustained belief in Abbott Laboratories (NYSE:ABT) as the best-performing large cap in its coverage year-to-date is bolstered by other positives such as business momentum in diabetes care, favorable trends in diagnostics, stability in nutrition, and strength in established pharmaceuticals. Abbott Laboratories (NYSE:ABT) is a leading global healthcare company that manufactures a wide range of branded generic medications, medical devices, diagnostics, and nutritional items. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio

Guggenheim Reiterates a Buy Rating on AbbVie (ABBV) With a $216 PT
Guggenheim Reiterates a Buy Rating on AbbVie (ABBV) With a $216 PT

Yahoo

time13 minutes ago

  • Yahoo

Guggenheim Reiterates a Buy Rating on AbbVie (ABBV) With a $216 PT

AbbVie Inc. (NYSE:ABBV) is one of the top low volatility healthcare stocks to buy now. In a report released on July 22, Vamil Divan from Guggenheim reiterated a Buy rating on AbbVie Inc. (NYSE:ABBV) with a price target of $216.00. A pharmacist handing out a pharmaceutical drug to a patient in a drug store or chemist. AbbVie Inc. (NYSE:ABBV) reported that net revenues in Q1 reached $13.343 billion, reflecting an 8.4% growth on a reported basis or 9.8% on an operational basis. Global net revenues for the quarter for the Immunology portfolio rose to $6.264 billion, reflecting a growth of 16.6% on a reported basis or 18.1% on an operational basis. AbbVie Inc. (NYSE:ABBV) also experienced growth in global net revenues in the Neuroscience portfolio to $2.282 billion, reflecting a 16.1% increase on a reported basis or 17% on an operational basis. AbbVie Inc. (NYSE:ABBV) is a research-based pharmaceutical company that develops and sells products to treat chronic diseases in oncology, gastroenterology, rheumatology, dermatology, virology, and various other serious health conditions. While we acknowledge the potential of ABBV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

VAALCO Schedules Second Quarter 2025 Earnings Release and Conference Call
VAALCO Schedules Second Quarter 2025 Earnings Release and Conference Call

Yahoo

time13 minutes ago

  • Yahoo

VAALCO Schedules Second Quarter 2025 Earnings Release and Conference Call

HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY) ('Vaalco' or the 'Company') today announced the timing of its second quarter 2025 earnings release and conference call. The Company will issue its second quarter 2025 earnings release on Thursday, August 7, 2025 after the close of trading on the New York Stock Exchange and host a conference call to discuss its financial and operational results on Friday morning, August 8, 2025 at 9:00 a.m. Central Time (10:00 a.m. Eastern Time and 3:00 p.m. London Time.) Interested parties in the United States may participate toll-free by dialing (833) 685-0907. Interested parties in the United Kingdom may participate toll-free by dialing 08082389064. Other international parties may dial (412) 317-5741. Participants should ask to be joined to the 'Vaalco Energy Earnings Conference Call.' This call will also be webcast on VAALCO's website at An audio replay will be available on the Company's website following the call. About Vaalco Vaalco, founded in 1985 and incorporated under the laws of Delaware, is a Houston, Texas, USA based, independent energy company with a diverse portfolio of production, development and exploration assets across Gabon, Egypt, Côte d'Ivoire, Equatorial Guinea, Nigeria and Canada. For Further Information Vaalco Energy, Inc. (General and Investor Enquiries) +00 1 713 543 3422 Website: Al Petrie Advisors (US Investor Relations) +00 1 713 543 3422 Al Petrie / Chris Delange Buchanan (UK Financial PR) +44 (0) 207 466 5000 Ben Romney / Barry Archer Vaalco@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store